AARTIPHARM

Aarti Pharmalabs Ltd was incorporated in 2019 through a demerger from Aarti Industries Limited. The company operates in the pharmaceuticals and nutraceuticals industries, specializing in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, xanthine derivatives, pharmaceuticals, and nutraceuticals. It provides end-to-end solutions from process development to commercial manufacturing. Aarti Pharmalabs maintains a strong global presence with exports to regulated markets including India, the United States, the European Union, and Japan. The company is recognized as a key player in the 'China+1' strategy, utilizing fully backward-integrated manufacturing processes to enhance supply chain resilience.